T Vega
Overview
Explore the profile of T Vega including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez-Rios L, Vega T, Chirino R, Jung J, Davis B, Perez-Machin R, et al.
Toxicol Rep
. 2018 Nov;
5:1021-1031.
PMID: 30386730
Xanthigen is a nutraceutical combination for weight management capable of increasing energy expenditure via uncoupling protein 1 (UCP-1) in white adipose tissue. It consists of brown seaweed extract, rich in...
2.
Bangert M, Gil H, Oliva J, Delgado C, Vega T, DE Mateo S, et al.
Epidemiol Infect
. 2016 Dec;
145(4):715-722.
PMID: 27916023
The intensity of annual Spanish influenza activity is currently estimated from historical data of the Spanish Influenza Sentinel Surveillance System (SISSS) using qualitative indicators from the European Influenza Surveillance Network....
3.
Jimenez-Jorge S, DE Mateo S, Delgado-Sanz C, Pozo F, Casas I, Garcia-Cenoz M, et al.
Euro Surveill
. 2015 Jul;
20(28).
PMID: 26212144
We aimed to estimate influenza vaccine effectiveness (VE) against laboratory-confirmed influenza during three influenza seasons (2010/11 to 2012/2013) in Spain using surveillance data and to compare the results with data...
4.
Jimenez-Jorge S, Pozo F, DE Mateo S, Delgado-Sanz C, Casas I, Garcia-Cenoz M, et al.
Euro Surveill
. 2014 Mar;
19(9).
PMID: 24626206
Adjusted early estimates of the 2013/14 influenza vaccine effectiveness (VE) in Spain for all age groups was 35% (95% CI: -9 to 62), 33% (95% CI: -33 to 67) and...
5.
Vega T, Breccia G, Gil M, Zorzoli R, Picardi L, Nestares G
Plant Physiol Biochem
. 2012 Nov;
61:103-7.
PMID: 23123550
The objective of this work was to evaluate the in vivo acetohydroxyacid synthase (AHAS) activity response to imidazolinones and its possible use as a selection method for evaluating AHAS inhibitor...
6.
Jimenez-Jorge S, DE Mateo S, Pozo F, Casas I, Garcia Cenoz M, Castilla J, et al.
Euro Surveill
. 2012 Apr;
17(12).
PMID: 22490308
We present early estimates of influenza vaccine effectiveness (VE) in the population targeted for vaccination, during 25 December 2011 to 19 February 2012. The adjusted VE was 55% (95% CI:...
7.
Mayor M, Nestares G, Vega T, Zorzoli R, Picardi L
Methods Mol Biol
. 2010 Jan;
589:271-80.
PMID: 20099109
Sunflower (Helianthus annuus L.) has been cultivated both as an oilseed and as an ornamental plant. Several protocols have been described for the micropropagation, direct plant regeneration by organogenesis being...
8.
Diez M, Bleda M, Alcaide J, Castells C, Cardenal J, Dominguez A, et al.
Eur J Public Health
. 2005 Jul;
15(4):343-9.
PMID: 16014664
Background: Health system delay (HSD) is an important issue in tuberculosis (TB) control. This report investigates HSD and associated factors in a cohort of Spanish culture-confirmed TB patients. Methods: Data...
9.
Diez M, Bleda M, Alcaide J, Caloto T, Castells C, Cardenal J, et al.
Eur J Public Health
. 2004 Jul;
14(2):151-5.
PMID: 15230500
Background: Patient delay was investigated in a cohort of TB patients identified from May 1996 until April 1997 in 13 Autonomous Regions in Spain. The study covered almost 67% of...
10.
Aguilera J, Paget W, Mosnier A, Heijnen M, Uphoff H, Velden J, et al.
Eur J Epidemiol
. 2003 Sep;
18(8):751-4.
PMID: 12974549
We reviewed the case definitions used by 21 influenza sentinel-based surveillance networks in Western Europe. Two clinical syndromes were used with a wide range of case definitions that nevertheless shared...